BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Costanzo G, Cordeddu W, Chessa L, Del Giacco S, Firinu D. COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic. World J Clin Cases 2021; 9(20): 5352-5357 [PMID: 34307589 DOI: 10.12998/wjcc.v9.i20.5352]
URL: https://www.wjgnet.com/2307-8960/full/v9/i20/5352.htm
Number Citing Articles
1
Haitham M.H. Qutob, Ramadan A. Saad, Hamza Bali, Abdulaziz Osailan, Jumana Jaber, Emad Alzahrani, Jamilah Alyami, Hani Elsayed, Raed Alserihi, Osama A. Shaikhomar. Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic diseaseMedicina Clínica 2022; 159(12): 569 doi: 10.1016/j.medcli.2022.02.013
2
Drew Provan, Adrian C Newland. Investigational drugs for immune thrombocytopeniaExpert Opinion on Investigational Drugs 2022; 31(7): 715 doi: 10.1080/13543784.2022.2075340
3
Haitham M.H. Qutob, Ramadan A. Saad, Hamza Bali, Abdulaziz Osailan, Jumana Jaber, Emad Alzahrani, Jamilah Alyami, Hani Elsayed, Raed Alserihi, Osama A. Shaikhomar. Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic diseaseMedicina Clínica (English Edition) 2022; 159(12): 569 doi: 10.1016/j.medcle.2022.02.029